Good Morning America: New Report on the Effect of Weight Loss Drugs on Heart Disease
A new study found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.
The findings of the STEP-HFpEF DM trial, led by Dr. Mikhail Kosiborod, cardiologist and vice president for research at Saint Luke’s Mid America Heart Institute, were announced over the weekend at the American College of Cardiology Scientific Session.
Good Morning America discussed the study's findings below.
Relevant News
News
The Afternoon Drive: How to Keep Your Kidneys Healthy
News
Ingram's: Cancer’s Bell Tolls: How Health Systems Are Responding to Rising Rates of Chronic Disease
Patient Stories
New Treatment Gives Heart Patient a Fresh Start
News
KMBC: Meet The American Shepherd Bringing Cheer to Heart Patients at Saint Luke's
Article
Protecting Your Heart Through Primary Care
News